Suppr超能文献

肾移植术后第一年的尿路感染:治疗无症状菌尿的潜在益处。

Urinary Tract Infections in the First Year Post-Kidney Transplantation: Potential Benefits of Treating Asymptomatic Bacteriuria.

作者信息

Kotagiri P, Chembolli D, Ryan J, Hughes P D, Toussaint N D

机构信息

The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Monash Health, Clayton, Victoria, Australia.

出版信息

Transplant Proc. 2017 Nov;49(9):2070-2075. doi: 10.1016/j.transproceed.2017.07.008.

Abstract

BACKGROUND

Urinary tract infections (UTIs) are the commonest infectious complication in kidney transplant recipients (KTRs). No recommendations exist regarding treatment of asymptomatic bacteriuria. We aimed to identify potential risk factors and microbiological profile for UTIs, the role of treatment of asymptomatic bacteriuria, and effects on graft outcomes of bacteriuria within the first year post-transplantation.

METHODS

We performed a retrospective analysis of UTIs in KTRs transplanted between January 2012 and December 2013 in 2 transplantation centers. Patients were routinely commenced on prophylactic sulfamethoxazole-trimethoprim. Clinical and microbiological data were analyzed for the first year following transplantation.

RESULTS

In all, 276 KTRs were evaluated; 67% were men, with a mean age of 51 years. At 12 months post-transplantation 158 (57%) KTRs had no bacteriuria, 75 (27%) had asymptomatic bacteriuria, 21 (8%) had symptomatic UTIs without further complication, and 22 (8%) with UTIs developed either pyelonephritis or urosepsis. Most frequent pathogens identified were Enterococcus faecalis and Escherichia coli, and 36% of organisms were multidrug resistant. Female sex was a risk factor for infection (P = .002), and presence of a double-J ureteral stent significantly increased the risk of asymptomatic bacteriuria and symptomatic UTIs (P = .003). Diabetes, age, and prior transplantation did not increase risk. Presence of infection was not associated with increased rejection, with similar renal function at 12 months. For episodes of bacteriuria (n = 420, asymptomatic n = 324), untreated asymptomatic bacteriuria (n = 185) followed by symptomatic UTI with the same organism was significantly higher (P = .002) compared with cases of treated asymptomatic bacteriuria (n = 139).

CONCLUSION

Bacteriuria post-kidney transplantation is common, affecting nearly half of KTRs in the first year after transplantation. Treatment of asymptomatic bacteriuria may be beneficial to prevent subsequent episodes of symptomatic UTIs.

摘要

背景

尿路感染(UTIs)是肾移植受者(KTRs)中最常见的感染性并发症。目前对于无症状菌尿的治疗尚无相关推荐。我们旨在确定UTIs的潜在危险因素和微生物学特征、无症状菌尿治疗的作用以及移植后第一年菌尿对移植肾结局的影响。

方法

我们对2012年1月至2013年12月在2个移植中心接受移植的KTRs的UTIs进行了回顾性分析。患者常规开始使用复方新诺明进行预防。对移植后第一年的临床和微生物学数据进行分析。

结果

总共评估了276例KTRs;67%为男性,平均年龄51岁。移植后12个月时,158例(57%)KTRs无菌尿,75例(27%)有无症状菌尿,21例(8%)有症状性UTIs且无进一步并发症,22例(8%)有UTIs并发肾盂肾炎或尿脓毒症。鉴定出的最常见病原体是粪肠球菌和大肠埃希菌,36%的菌株对多种药物耐药。女性是感染的危险因素(P = 0.002),双J输尿管支架的存在显著增加了无症状菌尿和有症状性UTIs的风险(P = 0.003)。糖尿病、年龄和既往移植并未增加风险。感染的存在与排斥反应增加无关,移植后12个月时肾功能相似。对于菌尿发作(n = 420,无症状n = 324),与治疗的无症状菌尿病例(n = 139)相比,未治疗的无症状菌尿(n = 185)随后出现相同病原体的有症状性UTI的情况显著更高(P = 0.002)。

结论

肾移植后菌尿很常见,在移植后的第一年影响近一半的KTRs。治疗无症状菌尿可能有助于预防随后的有症状性UTIs发作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验